Biomarkers and targets for diagnosis, prognosis and management of prostate, breast and bladder cancer
US6218529A · kind A · utility
70Cited by
9References
38Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 12, 1998 |
| Grant date | Apr 17, 2001 |
| Priority date | — |
| Expiry date | Jun 12, 2018 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are diagnostic techniques for the detection of human prostate, bladder and breast cancer. Genetic probes and methods useful in monitoring the progression and diagnosis of prostate, bladder and breast cancer are described. The invention relates particularly to probes and methods for evaluating the presence of RNA species that are differentially expressed in prostate, bladder and breast cancer compared to normal human prostate, benign prostatic hyperplasia, or normal bladder or breast tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.